|
Clinical Bottom Line |
|
Warfarin decreases the risk of stroke in patients with NVAF, with an increase in major bleeding episodes. Patients with NVAF who are <65, without a history of hypertension, previous stroke or TIA or diabetes are at a low risk of stroke, even if not treated. |
Citation
: Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994;154:1449-57.Clinical Question: In a patient with NVAF, does warfarin decrease the risk of stroke compared with no therapy?
Search terms: atrial fibrillation and anticoagulation in MEDLINE
The Study
The Evidence
|
Outcome |
ARR |
NNT |
|
Stroke |
0.031 |
32 |
|
Death |
0.018 |
55 |
|
Major haemorrhage |
0.003 |
NNH 333 |
|
Risk Categories |
CER (%) |
EER |
ARR |
NNT |
|
Age < 65 no risk factors
= 1 risk factor |
1 (0.3 to 3)
4.9(3 to 8.1)
|
1(0.3 to 3)
1.7(0.8 to 3.9) |
0
0.032 |
-
33 |
|
Age 65-75 no risk factors
= 1 risk factor |
4.3(2.7 to 7.1)
5.7(3.9 to 8.3) |
1.7 (0.9 to 3.4) |
0.032
0.040 |
33
25 |
|
Age > 75 no risk factors
= 1 risk factor |
8.1(4.7 to 13.9) |
1.7(0.5 to 5.2)
1.2 (0.3-5.0) |
.018
.069 |
55
15 |
Comments:
Appraised by: Straus, 1997; Expiry Date: Sept 1999
Click here to comment on this CAT |
![]() |